Showing results (1-10 of 230) with videos related to
Sort By:
Pageof 23
Expert Opinion on Emerging Drugs|March 1, 2006
Emerging drug therapies for benign prostatic hyperplasiaTravis L Bullock, Gerald L AndrioleUrology|January 16, 2008
Is there a better way to biopsy the prostate? Prospects for a novel transrectal systematic biopsy approachGerald L Andriole, Travis L Bullock, Jay S Belani, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 18, 2014
Update of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialGerald L AndrioleUrology|April 21, 2009
Overview of pivotal studies for prostate cancer risk reduction, past and presentGerald L AndrioleReviews in Urology|January 30, 2010
The impact of prostate cancer and hormonal therapy on boneGerald L AndrioleEuropean Urology|June 20, 2003
Safety and tolerability of the dual 5alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasiaGerald L Andriole, Roger KirbyThe Journal of Urology|January 18, 2011
Cost-effectiveness of prostate specific antigen screening in the United States: extrapolating from the European study of screening for prostate cancerAlex Shteynshlyuger, Gerald L AndrioleThe Urologic Clinics of North America|February 16, 2010
Prostate cancer: to screen or not to screen?Alex Shteynshlyuger, Gerald L AndrioleReviews in Urology|September 21, 2006
Three-Dimensional (3D) Vision: Does It Improve Laparoscopic Skills? An Assessment of a 3D Head-Mounted Visualization SystemSam B Bhayani, Gerald L AndrioleAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
The case for prostate cancer risk reduction by 5-alpha reductase inhibitorsYoussef S Tanagho, Gerald L AndriolePageof 23